743
Participants
Start Date
December 7, 2015
Primary Completion Date
May 30, 2019
Study Completion Date
February 7, 2024
Nivolumab
Specified Dose on Specified Days
Sorafenib
Specified Dose on Specified Days
Local Institution - 0011, Hong Kong
Local Institution - 0062, Bergamo
Local Institution - 0121, Tainan City
Local Institution - 0132, Tainan City
Local Institution - 0075, Brussels
Local Institution - 0038, Vienna
Local Institution - 0005, Camperdown
Local Institution - 0091, Leuven
Local Institution - 0041, Bern
Local Institution - 0002, Heidelberg
Local Institution - 0001, Clayton
Local Institution - 0003, Prahran
Local Institution - 0077, Liège
Local Institution - 0040, Basel
Local Institution - 0007, Adelaide
Local Institution - 0008, Nedlands
Local Institution - 0039, Graz
Local Institution - 0099, Taipei
Local Institution - 0083, New York
Local Institution - 0063, Orbassano
Local Institution - 0093, New York
Local Institution - 0116, Goyang-si
Local Institution - 0120, Taipei
Local Institution - 0036, Berlin
Local Institution - 0010, Santiago Compostela
Local Institution - 0095, Philadelphia
Local Institution - 0019, Philadelphia
Local Institution - 0055, Milan
Local Institution - 0034, Hamburg
Local Institution - 0016, Charlotte
Local Institution - 0085, Majadahonda - Madrid
Local Institution - 0009, Pamplona
Local Institution - 0074, Toulouse
Local Institution - 0082, Haifa
Local Institution - 0128, Taoyuan
Local Institution - 0068, Pessac
Local Institution - 0073, Montpellier
Local Institution - 0070, Rennes
Local Institution - 0066, Birmingham
Local Institution - 0071, La Tronche
Local Institution - 0133, Taichung
Local Institution - 0125, Daegu
Local Institution - 0037, Essen
Local Institution - 0058, Petah Tikva
Local Institution - 0064, Siena
Local Institution - 0050, Madison
Local Institution - 0035, Mainz
Local Institution - 0118, Jeollanam-do
Local Institution - 0072, Lille
Local Institution - 0167, Frankfurt
Local Institution - 0061, Chicago
Local Institution - 0059, Tel Aviv
Local Institution - 0069, Lyon
Ochsner Clinic Foundation, New Orleans
Local Institution - 0030, Tübingen
UT Southwestern Medical Center, Dallas
Local Institution - 0067, Paris
Scott & White Memorial Hospital And Clinic, Temple
Local Institution - 0017, San Antonio
Local Institution - 0023, Gdansk
Local Institution - 0033, Munich
Local Institution - 0054, Benevento
Local Institution - 0129, Kaohsiung County
Local Institution - 0020, Los Angeles
Local Institution - 0060, Jerusalem
Local Institution - 0032, Regensburg
Local Institution - 0015, San Francisco
Local Institution - 0084, San Francisco
Local Institution - 0026, Seattle
University of Washington - Seattle Cancer Care Alliance, Seattle
Local Institution - 0139, Beijing
Local Institution - 0137, Beijing
Local Institution - 0140, Beijing
Local Institution - 0141, Beijing
Local Institution - 0096, Moscow
Local Institution - 0166, Dalian
Local Institution - 0136, Changchun
Local Institution - 0163, Changchun
Local Institution - 0142, Harbin
Local Institution - 0013, Singapore
Local Institution - 0145, Shanghai
Local Institution - 0151, Shanghai
Local Institution - 0135, Nanjing
Local Institution - 0169, Changzhou
Local Institution - 0164, Hefei
Local Institution - 0159, Tianjin
Local Institution - 0014, Singapore
Local Institution - 0173, Hangzhou
Local Institution - 0146, Hangzhou
Local Institution - 0152, Fuzhou
Local Institution - 0148, Changsha
Local Institution - 0162, Changsha
Local Institution - 0161, Guangzhou
Local Institution - 0157, Guangzhou
Local Institution - 0144, Guangzhou
Local Institution - 0158, Nanning
Local Institution - 0138, Xi'an
Local Institution - 0126, Shinjuku-ku
Local Institution - 0110, Kawasaki-shi
Local Institution - 0112, Yokohama
Local Institution - 0104, Yokohama
Local Institution - 0100, Chiba
Local Institution - 0127, Ogaki-shi
Local Institution - 0113, Suita
Local Institution - 0106, Osaka-Sayama-Shi
Local Institution - 0111, Kyoto
Local Institution - 0103, Matsuyama
Local Institution - 0107, Kurume-shi
Local Institution - 0115, Saga
Local Institution - 0105, Kanazawa
Local Institution - 0043, Calgary
Local Institution - 0044, Vancouver
Local Institution - 0042, Québec
Local Institution - 0029, Brno
Local Institution - 0027, Hradec Králové
Local Institution - 0028, Olomouc
Local Institution - 0031, Leipzig
Local Institution - 0012, Hong Kong
Local Institution - 0102, Sapporo
Local Institution - 0130, Sapporo
Local Institution - 0131, Chiyoda-ku
Local Institution - 0114, Mitaka-shi
Local Institution - 0108, Musashino-shi
Local Institution - 0101, Hiroshima
Local Institution - 0056, Warsaw
Local Institution - 0045, Wroclaw
Local Institution - 0117, Seoul
Local Institution - 0123, Seoul
Local Institution - 0119, Seoul
Local Institution - 0122, Seoul
Local Institution - 0124, Seoul
Local Institution - 0065, Alicante
Local Institution - 0088, Gothenburg
Local Institution - 0087, Stockholm
Local Institution - 0080, London
Local Institution - 0078, London
Local Institution - 0079, Glasgow
Local Institution - 0081, Liverpool
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY